If you have been reading about research chemical and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-03-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | Linear, fifteen residues |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Approximate mass | 1419 Da | Value reported for the free peptide |
| Reported origin | Fragment of a gastric juice protein | Used as the design template |
| Common synonyms | Body protection compound 157; PL 14736 | Naming varies across papers and suppliers |
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
There also exists a faction of aliens who actively oppose Colonization. They are the same species as the Alien Bounty Hunter(s), free from the effects of black oil infection. The Rebels are distinguished by their grotesque appearance: the orifices on their face are morphed shut to avoid absorption of the parasitic black oil. Colonization has apparently begun in the Rebels' home environment, but members of this species are spared gestation to become Bounty Hunters for the Colonists' ongoing conquest efforts. Although enemies of the Colonists, the Rebels can also be hostile to humanity; they carry prod-like weapons that can quickly incinerate a human and do not hesitate to use them. They burn abductees with chips in their necks at abduction sites in attempts to prevent colonization from proceeding. The Rebels have a vested interest in keeping the Colonists from finding out that a successful hybrid has been created. While the Rebels had an opportunity to destroy the hybrid, Cassandra Spender, they choose to let her survive in the hope that the Syndicate will join them in fighting the Colonists. If they refuse, Cassandra can be used to expose the truth and the conspiracy. The Rebels go so far as to infiltrate the Syndicate and bring up the possibility of fighting the Colonists. However, the Syndicate decides that fighting the Colonists would be futile.
The strength of venom differs markedly between species and even more so between families, as measured by median lethal dose (LD50) in mice. Subcutaneous LD50 varies by over 140-fold within elapids and by more than 100-fold in vipers. The amount of venom produced also differs among species, with the Gaboon viper able to potentially deliver from 450 to 600 milligrams of venom in a single bite, the most of any snake. Opisthoglyphous colubrids have venom ranging from life-threatening (in the case of the boomslang) to barely noticeable (as in Tantilla).
Carlos do Carmo said he did not know the reason why Dias had said: "If you want Rui Pedro close the borders". Hernâni Carvalho ended the interview by telling Carlos do Carmo:"I would like to leave this enigma: by curiosity, by paradox or by pure coincidence, two days before Rui Pedro disappeared (...) an eleven year old boy disappeared (...) no one found out anything about him either"Júlia Pinheiro questioned Francisco Moita Flores in 2011 about the police not having connected the fact that Afonso Dias had ties to Holland. Moita Flores agreed that it was a path that should have been followed. It was also questioned the fact Dias' financial life was not investigated and that during the reconstitution, the camera stopped recording the event, without it being noticed. Manuel Mendonça said that the police "joked around" with the case for three or four years, without recording things, gathering samples or DNA tests, always thinking that Mendonça would come back because he was playing or had run from home.
== Research and career == Franz became an assistant professor at Duke University in 2003. She is an Associate member of the Duke Cancer Institute. In 2005, Franz was awarded an National Science Foundation CAREER Award. She was made a Sloan Research Fellow in 2008 and promoted to professor in 2015. Franz has investigated the use of cellular metals in antimicrobial resistance. For example, by disrupting the amount of iron in a cell it is possible to withhold an essential pathogen, limiting the growth of microbes. On the other hand, copper can be used to control the growth of microbes, and immune cells appear to move copper to kill pathogens. At the same time, pathogens try to use copper to enhance their resistance and likelihood of survival. Franz attempts to use copper in the same way as biological systems to target antimicrobial agents. She has looked at iron and copper as ionophores; which are important in the virulence of Cryptococcus neoformans. Franz also works on anti-cancer prochelators; molecules that do not have much affinity for metal ions, but can be triggered until they undergo a chemical conversion. Cancer cells have different metallomes than normal cells. For example, prostate cancer results in the overexpression of copper trafficking proteins, causing a high level of copper. She looks to target these copper ions by creating prochelators that become activated in the microenvironment of cancer.
Sources: en.wikipedia.org
Cronulla-Sutherland Sharks supplements saga (2013) – in February 2013, the Cronulla-Sutherland Sharks, a professional rugby league team participating in the National Rugby League (NRL), were investigated by the ASADA and the WADA over the legality of its supplements program during the preseason and the regular 2011 NRL season. In August 2014, the players were found guilty of having used the banned peptide CJC-1295, resulting in the suspensions of fourteen players who were part of the program.
=== Pharmacokinetics === Since imidazolines are sympathomimetic agents, their primary effects appear on α adrenergic receptors, with little if any effect on β adrenergic receptors. Like other imidazolines, Oxymetazoline is readily absorbed orally. Effects on α receptors from systemically absorbed oxymetazoline hydrochloride may persist for up to 7 hours after a single dose. The elimination half-life in humans is 5–8 hours. It is excreted unchanged both by the kidneys (30%) and in feces (10%).
Starfish or sea stars are a class of echinoderms generally shaped like a star polygon. (In common usage, these names are also often applied to ophiuroids, which are correctly referred to as brittle stars or basket stars.) Starfish are also known as asteroids because they form the taxonomic class Asteroidea (). About 1,900 species of starfish live on the seabed, and are found in all the world's oceans, from warm, tropical zones to frigid, polar regions. They can occur from the intertidal zone down to abyssal depths, at 6,000 m (20,000 ft) below the surface. Starfish typically have a central disc and usually five arms, though some species have a larger number of arms. The aboral or upper surface may be smooth, granular or spiny, and is covered with overlapping plates. Many species are brightly coloured in various shades of red or orange, while others are blue, grey or brown. Starfish have tube feet operated by a hydraulic system and a mouth at the centre of the oral or lower surface. They are opportunistic feeders and are mostly predators on benthic invertebrates. Several species have specialized feeding behaviours including eversion of their stomachs and suspension feeding. They have complex life cycles and can reproduce both sexually and asexually. Most can regenerate damaged parts or lost arms and they can shed arms as a means of defense. The Asteroidea occupy several significant ecological roles. Some, such as the ochre sea star (Pisaster ochraceus) and the reef sea star (Stichaster australis), serve as keystone species, with an outsize impact on their environment.
Protein misfolding cyclic amplification (PMCA) is an amplification technique (conceptually like polymerase chain reaction (PCR) but not involving nucleotides) to multiply misfolded prions originally developed by Soto and colleagues. It is a test for spongiform encephalopathies like chronic wasting disease (CWD) or bovine spongiform encephalopathy (BSE).
== History == The toxin was first described in detail in 1969 by two Brazilian researchers from University of Campinas, Júlia Prado-Franceschi and Oswaldo Vital-Brazil. The snake C-type lectin convulxin was reported to activate platelets in a similar way to collagen in the late 1970s, but this was only announced after the discovery of the association with the FcR γ-chain and after it was recognized to mediate activation through GPVI. Now this toxin is widely used to study mammalian platelet receptors.
Sources: en.wikipedia.org
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.
The sequence corresponds to a segment of a naturally occurring gastric protein, so related sequence material exists in the body. The peptide itself as sold and studied is a laboratory-synthesized product. Whether an identical free peptide circulates naturally is not established.
No major regulatory agency has approved it as a medicine for any indication. It appears in research supply channels and, in some jurisdictions, in compounded preparations. Clinical use therefore sits outside standard approved-product pathways, and regulatory status varies by country.
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.